In addition, CELF1 jointly acts as a modulator of translation with miR-222, a significantly lowered miRNA in the blood of AD patients [173,174], and enhances the deadenylation and degradation of miR-122, an upregulated miRNA in the brain with AD patients [175,176]. The gene discussed is CELF1; the disease is Alzheimer disease.